Panel backs Pfizer drug for juvenile arthritis
(Reuters)
|
|
Wednesday, 29 November 2006 |
|
Reuters - Pfizer Inc.'s pain
reliever Celebrex should be approved for treating rheumatoid
arthritis in children, a U.S. advisory panel said in a 15-1
vote on Wednesday despite concerns about the drug's long-term
safety. |
